Xilio Therapeutics (XLO)
(Delayed Data from NSDQ)
$0.78 USD
+0.05 (7.51%)
Updated Oct 4, 2024 03:59 PM ET
After-Market: $0.76 -0.02 (-2.56%) 7:22 PM ET
3-Hold of 5 3
F Value A Growth D Momentum C VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
11/14/2024
Time: -- |
9/2024 | $-0.25 | 0.00% |
Earnings Summary
For their last quarter, Xilio Therapeutics (XLO) reported earnings of -$0.24 per share, missing the Zacks Consensus Estimate of -$0.23 per share. This reflects a negative earnings surprise of 4.35%. Look out for XLO's next earnings release expected on November 14, 2024. For the next earning release, we expect the company to report earnings of -$0.25 per share, reflecting a year-over-year increase of 59.02%.
Earnings History
Price & Consensus
Zacks News for XLO
Xilio's (XLO) Shares Surge 79.8% in a Month: Here's Why
XLO: What are Zacks experts saying now?
Zacks Private Portfolio Services